Teva’s Cubicin Authorized Generic Is First Rival To Merck’s Brand
Executive Summary
Teva launched an authorized generic version of Merck’s blockbuster antibiotic, while Pfizer did not provide an update on the timeline of a generic launch for which a court decision paved the way.